The initiation of coverage with a Buy rating and a specific price target of $37 by a reputable analyst from Jefferies is likely to positively impact the stock price of Syndax Pharmaceuticals in the short term. Such analyst ratings often influence investor sentiment and can lead to increased buying activity.